RA Capital Nexus Fund, L.P.'s Net Worth

-$21.4 Million

Who is RA Capital Nexus Fund, L.P.?

RA Capital Nexus Fund, L.P. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Tyra Biosciences, Inc., Eliem Therapeutics, Inc., Aerovate Therapeutics, Inc., 89bio, Inc., Akouos, Inc., Nkarta, Inc., Icosavax, Inc., Solid Biosciences Inc., and Black Diamond Therapeutics, Inc..

SEC CIK

RA Capital Nexus Fund, L.P.'s CIK is 0001780117

Past Insider Trading and Trends

2021 was RA Capital Nexus Fund, L.P.'s most active year for acquiring shares with 15 total transactions. RA Capital Nexus Fund, L.P.'s most active month to acquire stocks was the month of May. 2021 was RA Capital Nexus Fund, L.P.'s most active year for disposing of shares, totalling 17 transactions. RA Capital Nexus Fund, L.P.'s most active month to dispose stocks was the month of July. 2023 saw RA Capital Nexus Fund, L.P. paying a total of $54,678,160.67 for 4,564,619 shares, this is the most they've acquired in one year. In 2020 RA Capital Nexus Fund, L.P. cashed out on 30,687,585 shares for a total of $0.00, their largest year based on trade value.